450 related articles for article (PubMed ID: 11016642)
1. Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMP.
Shailubhai K; Yu HH; Karunanandaa K; Wang JY; Eber SL; Wang Y; Joo NS; Kim HD; Miedema BW; Abbas SZ; Boddupalli SS; Currie MG; Forte LR
Cancer Res; 2000 Sep; 60(18):5151-7. PubMed ID: 11016642
[TBL] [Abstract][Full Text] [Related]
2. Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics.
Forte LR
Pharmacol Ther; 2004 Nov; 104(2):137-62. PubMed ID: 15518884
[TBL] [Abstract][Full Text] [Related]
3. The uroguanylin gene (Guca1b) is linked to guanylin (Guca2) on mouse chromosome 4.
Whitaker TL; Steinbrecher KA; Copeland NG; Gilbert DJ; Jenkins NA; Cohen MB
Genomics; 1997 Oct; 45(2):348-54. PubMed ID: 9344659
[TBL] [Abstract][Full Text] [Related]
4. Guanylin stimulation of Cl- secretion in human intestinal T84 cells via cyclic guanosine monophosphate.
Forte LR; Eber SL; Turner JT; Freeman RH; Fok KF; Currie MG
J Clin Invest; 1993 Jun; 91(6):2423-8. PubMed ID: 8390480
[TBL] [Abstract][Full Text] [Related]
5. Uroguanylin inhibits proliferation of pancreatic cancer cells.
Kloeters O; Friess H; Giese N; Buechler MW; Cetin Y; Kulaksiz H
Scand J Gastroenterol; 2008; 43(4):447-55. PubMed ID: 18365910
[TBL] [Abstract][Full Text] [Related]
6. Guanylin and related peptides.
Bełtowski J
J Physiol Pharmacol; 2001 Sep; 52(3):351-75. PubMed ID: 11596856
[TBL] [Abstract][Full Text] [Related]
7. Guanylin mRNA expression in human intestine and colorectal adenocarcinoma.
Cohen MB; Hawkins JA; Witte DP
Lab Invest; 1998 Jan; 78(1):101-8. PubMed ID: 9461126
[TBL] [Abstract][Full Text] [Related]
8. Guanylin regulatory peptides: structures, biological activities mediated by cyclic GMP and pathobiology.
Forte LR
Regul Pept; 1999 May; 81(1-3):25-39. PubMed ID: 10395405
[TBL] [Abstract][Full Text] [Related]
9. Guanylyl cyclase receptors and guanylin-like peptides in reptilian intestine.
Krause WJ; Freeman RH; Eber SL; Hamra FK; Currie MG; Forte LR
Gen Comp Endocrinol; 1997 Aug; 107(2):229-39. PubMed ID: 9245531
[TBL] [Abstract][Full Text] [Related]
10. Porcine guanylin and uroguanylin: cDNA sequences, deduced amino acid sequences, and biological activity of the chemically synthesized peptides.
Mägert HJ; Hill O; Zucht HD; Martin S; Meyer M; Forssmann WG; Adermann K
Biochem Biophys Res Commun; 1999 May; 259(1):141-8. PubMed ID: 10334930
[TBL] [Abstract][Full Text] [Related]
11. The intestinal guanylin system and seawater adaptation in eels.
Takei Y; Yuge S
Gen Comp Endocrinol; 2007; 152(2-3):339-51. PubMed ID: 17561018
[TBL] [Abstract][Full Text] [Related]
12. Guanylin peptides: cyclic GMP signaling mechanisms.
Forte LR; Freeman RH; Krause WJ; London RM
Braz J Med Biol Res; 1999 Nov; 32(11):1329-36. PubMed ID: 10559833
[TBL] [Abstract][Full Text] [Related]
13. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
14. Expression of guanylin is downregulated in mouse and human intestinal adenomas.
Steinbrecher KA; Tuohy TM; Heppner Goss K; Scott MC; Witte DP; Groden J; Cohen MB
Biochem Biophys Res Commun; 2000 Jun; 273(1):225-30. PubMed ID: 10873591
[TBL] [Abstract][Full Text] [Related]
15. Cellular effects of guanylin and uroguanylin.
Sindić A; Schlatter E
J Am Soc Nephrol; 2006 Mar; 17(3):607-16. PubMed ID: 16382016
[TBL] [Abstract][Full Text] [Related]
16. Regulation of intestinal uroguanylin/guanylin receptor-mediated responses by mucosal acidity.
Hamra FK; Eber SL; Chin DT; Currie MG; Forte LR
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2705-10. PubMed ID: 9122260
[TBL] [Abstract][Full Text] [Related]
17. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
[TBL] [Abstract][Full Text] [Related]
18. High salt intake increases uroguanylin expression in mouse kidney.
Potthast R; Ehler E; Scheving LA; Sindic A; Schlatter E; Kuhn M
Endocrinology; 2001 Jul; 142(7):3087-97. PubMed ID: 11416031
[TBL] [Abstract][Full Text] [Related]
19. Renal effects of uroguanylin and guanylin in vivo.
Carrithers SL; Hill MJ; Johnson BR; O'Hara SM; Jackson BA; Ott CE; Lorenz J; Mann EA; Giannella RA; Forte LR; Greenberg RN
Braz J Med Biol Res; 1999 Nov; 32(11):1337-44. PubMed ID: 10559834
[TBL] [Abstract][Full Text] [Related]
20. Endogenous expression of type II cGMP-dependent protein kinase mRNA and protein in rat intestine. Implications for cystic fibrosis transmembrane conductance regulator.
Markert T; Vaandrager AB; Gambaryan S; Pöhler D; Häusler C; Walter U; De Jonge HR; Jarchau T; Lohmann SM
J Clin Invest; 1995 Aug; 96(2):822-30. PubMed ID: 7543493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
